KRAS and colorectal cancer: Relevance of Pharmacogenomics and Multidisciplinary Management in a Young-Elderly Patient With <i>KRAS</i> Mutant Colorectal Cancer Treated With First-Line Aflibercept-Containing Chemotherapy.